Abstract
Background In major depressive disorder (MDD), patients often express subjective sleep complaints while polysomnographic studies report only subtle alterations in neural oscillations. We hypothesize that the study of aperiodic electroencephalographic (EEG) dynamics, a marker of excitation-to-inhibition balance, may bring new insights into our understanding of sleep abnormalities in MDD. Specifically, we investigate aperiodic neural activity during sleep and its relationships with the time of sleep, depression severity, and responsivity to antidepressant treatment.
Methods Polysomnography was recorded in 38 MDD patients (in unmedicated and 7d medicated states) and 38 age-matched healthy controls (N1=76). Aperiodic EEG activity was evaluated using the Irregularly Resampled Auto-Spectral Analysis with slopes’ means and intra-individual variability as outcome measures. Depression severity was assessed with the Hamilton Depression Rating Scale. We replicated the analysis using two independently collected datasets of medicated patients and controls (N2=60, N3=80).
Results Unmedicated patients showed flatter aperiodic slopes compared to controls during N2 (p-value=0.002) and steeper slopes compared to their later medicated state (p-values<0.02) during all sleep stages. Within unmedicated patients, slopes were flatter during late compared to early N2 sleep (p-value=0.006). Late N2 slopes further correlated with depression severity after 7d of antidepressant treatment (r=-0.34, p-value=0.04). Variability of slopes was increased in both unmedicated (p-values<0.03) and medicated states (p-values <0.006) of patients’ N2, N3, and REM sleep compared to controls.
Conclusion Flatter slopes of aperiodic EEG power with increased variability may reflect unstable, noisy neural activity due to increased excitation-to-inhibition balance, representing a new disease-relevant feature of sleep in MDD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All studies were approved by the Ethics committee of the University of Munich.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- AUC
- area under the curve
- E/I
- excitation-to-inhibition
- HAM-D
- Hamilton depression rating scale
- MDD
- major depressive disorder
- NaSSA
- noradrenergic and specific serotonergic antidepressants
- NDRI
- norepinephrine-dopamine reuptake inhibitor
- REM
- rapid eye movement
- SNRI
- serotonin-norepinephrine reuptake inhibitors
- SSRI
- selective serotonin reuptake inhibitors
- TCA
- tricyclic antidepressants
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.